ivabradine

FDA Drug Profile — ivabradine, Corlanor

Drug Details

Generic Name
ivabradine
Brand Names
ivabradine, Corlanor
Application Number
ANDA213276
Sponsor
Bionpharma Inc.
NDC Codes
9
Dosage Forms
TABLET, FILM COATED, SOLUTION, TABLET
Routes
ORAL
Active Ingredients
IVABRADINE HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE Ivabradine is a hyperpolarization-activated cyclic nucleotide-gated channel blocker indicated: To reduce the risk of hospitalization for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with reduced left ventricular ejection fraction. ( 1.1 ) 1.1 Heart Failure in Adult Patients Ivabradine tablets are indicated to reduce the risk of hospitalization for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with left ventricular ejection fraction ≤ 35%, who are in sinus rhythm with resting heart rate ≥ 70 beats per minute and either are on maximally tolerated doses of beta-blockers or have a contraindication to beta-blocker use.